Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Shelterin complex, specifically involving Telomeric Repeat-Binding Factor 2 (TRF2) and Protection of Telomeres Protein 1 (POT1), is a specialized protein assembly dedicated to protecting the ends of eukaryotic chromosomes (Palm & de Lange, 2008, Annu Rev Genet). TRF2 binds to double-stranded telomeric DNA and is crucial for the formation of T-loops, which sequester the chromosome ends from being recognized as double-strand breaks. POT1 binds to the single-stranded 3' overhang, preventing the activation of the ATR-mediated DNA damage response (Denchi & de Lange, 2007, Nature). Together, these proteins prevent inappropriate DNA repair activities, such as non-homologous end joining (NHEJ) and homology-directed repair (HDR), at telomeres. In many cancers, these proteins are overexpressed or mutated to allow for continued cell proliferation and avoidance of senescence (Pinzaru et al., 2016, Nat Genet). Therapeutic strategies targeting TRF2 and POT1 aim to uncap telomeres, selectively inducing apoptosis or senescence in malignant cells that rely on telomere maintenance for immortality. Small molecule inhibitors and G-quadruplex stabilizers are currently being explored to disrupt these complexes and trigger telomere dysfunction as a potent anti-cancer strategy.
Disruption of the TRF2 and POT1 complexes leads to telomere uncapping, which triggers a DNA damage response (DDR) at chromosome ends. This results in the formation of telomere-dysfunction induced foci (TIFs), leading to cell cycle arrest, senescence, or apoptosis in cancer cells (de Lange, 2005, Genes & Dev).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Telomeric repeat-binding factor 2 and Protection of telomeres protein 1 complex (TRF2-POT1 complex).